Clinical trial
REMISE Study: REMnant Biospecimen Investigation in SEpsis
NCT05684133 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REMISE Study: REMnant Biospecimen Investigation in SEpsis
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 25, 2022
- Completion date
- December 31, 2023
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.